Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Potent 5-lipoxygenase inhibitors from Yakult Honsha

Aug. 9, 1996

Alliance signed for asthma disease management program

Aug. 9, 1996

Hoechst Marion Roussel receives marketing approval for Allegra

Aug. 9, 1996

Raloxifene claimed as treatment for excess bradykinin-related conditions

July 26, 1996

Leukocyte elastase inhibitors reported by Sanofi Winthrop

July 26, 1996

FK-224 research update

July 26, 1996

Tryptase inhibitors described as immune-based inflammatory disorders treatment

July 26, 1996

Anti-IgE monoclonal antibody lawsuits settled

July 19, 1996

Kyoto Pharm. and Asahi Chem. to codevelop AKY-953

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...